Analysts
Latest news and updates related to analysts
About Analysts coverage
The Analysts news hub on Global Investing News tracks 147 recent headlines that matter to investors, policy watchers, and market strategists. Use this page to monitor how Analysts developments affect earnings expectations, sector rotation, supply chains, regulation, and cross-asset volatility. Stories are grouped by source type — market data, company announcements, regulatory filings, and expert analysis — so you can scan the signal quickly without wading through duplicate wire copy. When a headline links to a full article, you will find expanded context, key facts, and prediction-market angles where available. Bookmark this hub if you follow Analysts across quarters; new items are added as our crawl pipeline ingests fresh sources throughout the trading day.
Explore related topics
Latest Analysts headlines
Market Data
(5)5-star analysts reset Broadcom stock price target
5-star analysts reset Broadcom stock price target
Analysts say this restaurant chain has figured out how to feed everyone — GLP-1 users included
Analysts say this restaurant chain has figured out how to feed everyone — GLP-1 users included
Dell gets downgraded by UBS as analysts see little room for upside following recent stock run
Dell gets downgraded by UBS as analysts see little room for upside following recent stock run
BP Is Winning Back Stock Analysts as Buy Ratings Double
BP Is Winning Back Stock Analysts as Buy Ratings Double
2 Vanguard ETFs to Buy to Outperform the S&P 500 Over the Next Decade, According to Analysts
2 Vanguard ETFs to Buy to Outperform the S&P 500 Over the Next Decade, According to Analysts
Expert Analysis
(2)Credicorp (BAP) Q3 Preview: High Stakes for NIM Expansion as Analysts Target $25.59 EPS
Credicorp Ltd. (BAP) is scheduled to report its third-quarter 2026 earnings on November 9, with the market bracing for a significant test of the Peruvian financial giant's operational resilience. Wall Street analysts have set a high bar, with a consensus EPS estimate of $25.5872 on projected revenues of $6.71 billion. As the dominant financial services group in Peru, BAP's performance will be viewed as a critical barometer for the Andean region’s broader economic recovery. Key metrics to watch include the Net Interest Margin (NIM) and the Cost-of-Risk (CoR). Investors are particularly focused on whether BAP can maintain its efficiency ratio amid fluctuating interest rates and local inflationary pressures. Analysts will be scrutinizing the performance of Banco de Crédito del Perú (BCP), the group's flagship commercial bank, specifically looking for growth in the consumer lending portfolio and the continued digital transformation success of its 'Yape' platform, which has become a cornerstone of its fee-income strategy. Historically, Credicorp has demonstrated a robust ability to navigate political volatility, often delivering earnings surprises through disciplined provisioning and strong capital ratios. However, the current estimate represents a demanding year-over-year growth trajectory. A beat on the bottom line, coupled with a positive outlook for credit demand in 2027, could catalyze a breakout for the stock, which has recently traded in a consolidated range. Conversely, any deterioration in asset quality or a slowdown in loan growth could trigger a sharp market correction, given the premium valuation BAP commands relative to regional peers. The timing of the release during trading hours suggests heightened intraday volatility as institutional desks react to the headline figures and the subsequent management conference call.
A Prepares for Q3 Earnings: Analysts Eye Growth Amidst Market Volatility
Agilent Technologies (A) is set to report its fiscal third-quarter 2026 earnings after the market closes on August 26, 2026. The market will be closely watching for signs of continued resilience and growth from the life sciences and diagnostics giant, especially given the dynamic macroeconomic environment and its impact on R&D spending across various sectors. Analysts have set an average EPS estimate of $1.5154, with revenue projected at $1.88 billion. These figures suggest a moderate growth trajectory, reflecting the company's strong foundational position in analytical instrumentation and clinical diagnostics, but also acknowledging potential headwinds in certain end markets. Key metrics to watch during the earnings call include segment-specific performance, particularly in Agilent CrossLab Group (ACG) and Diagnostics and Genomics Group (DGG), which have historically been robust growth drivers. Investors will be keen to hear management's commentary on order trends, particularly from pharmaceutical, biotech, and academic research customers, as well as the impact of currency fluctuations. Gross margin performance and operating expenses will also be critical indicators of operational efficiency. Any updates on the supply chain situation and inventory levels will also provide valuable insights into the company's ability to meet demand. Furthermore, the outlook for the upcoming quarter and full fiscal year guidance will be paramount in shaping investor sentiment and the stock's immediate reaction. Historically, Agilent has demonstrated a consistent track record of meeting or exceeding analyst expectations, leveraging its diversified portfolio and global presence. However, recent quarters have seen some variability, making this report particularly important for confirming the company's trajectory. A beat on both top and bottom lines, accompanied by strong forward guidance, could provide a significant upside catalyst. Conversely, any significant deviation or cautious commentary on future demand could lead to downward pressure. The life sciences tools sector has experienced mixed fortunes recently, and Agilent's results will offer a bellwether for the broader industry's health. The stock's performance post-earnings will likely reflect not just the numbers themselves, but also the confidence management conveys regarding its strategic initiatives and market positioning.
Get alerts for this topic
Subscribe to receive updates about "Analysts"